Skip to main content

Tag: 2023

Wallenborn achieves a decade of GDP Certification

Wallenborn achieves a decade of GDP Certification

Luxembourg-based Wallenborn Transports is delighted to announce it has achieved ten years of Good Distribution Practice (GDP) certification, ensuring that the pharmaceutical product s in its care are authorised in compliance with European Union legislation.

Luxembourg, 15.11.2023

Ram Menon, Chief Commercial Officer explained, “in 2013, Wallenborn was the first own-fleet operator in Luxembourg to obtain GDP certification, to maintain the highest standards in healthcare transportation and to eliminate the need for manufacturer audits. Our dedicated GDP teams, located at our control tower in Luxembourg and on the roads across Europe have a singular focus – to ensure that the correct products are delivered in perfect condition to the appropriate recipients within a satisfactory timeframe”.  

Elements of Wallenborn’s GDP Certification include

  1. Legal and regulatory framework to ensure thorough understanding of, and compliance with regulations and guidelines. 
  2. Implementing and maintaining a robust Quality Management System is essential and includes procedures for pre-loading, loading and unloading, and maintaining the correct temperature range for products.
  3. Supply Chain Mapping to visualise the transportation process and identify potential risks and areas for improvement and implement safety and security protocols. 
  4. Temperature Mapping and Transport Qualification ensuring that products are transported under the correct temperature conditions.
  5. Staff and driver training to ensure the importance of understanding and maintaining the integrity of the cold chain for temperature-sensitive products.
  6. Trailer fleet cleaning protocols

For more information about our Wallenborn’s healthcare specialities, please visit www.wallenborn.com/healthcare  

Continue reading

From Conception to Execution- Wallenborn’s role in overcoming Covid-19

From Conception to Execution- Wallenborn’s role in overcoming Covid-19

Wallenborn’s dedicated GDP team played a significant role in a vital global initiative managed by Yusen Logistics during 2021 and 2022 to deliver 300 million doses of Covid-19 vaccines.

Wallenborn’s dedicated GDP team played a significant role in a vital global initiative managed by Yusen Logistics during 2021 and 2022 to deliver 300 million doses of Covid-19 vaccines.

Jason Breakwell, the Group Commercial Director at Wallenborn who was actively involved in the scoping, planning and execution of Wallenborn’s contribution to this intricate and extensive project, stated “it was a privilege and an extremely rewarding experience to participate in such a crucial life-saving initiative. One can easily imagine that the entire project, from its inception to the delivery of the ultimate dose, had to be carried out under the highest levels of confidentiality”. He further remarked: “Yusen entrusted Wallenborn from the outset and valued our proficiency in supply chain mapping, creating route risk assessments and collaborating with all stakeholders to deliver solutions that were resilient, adaptable, and dependable. Furthermore, our deployment of bi-temperature assets facilitated the safe and secure co-loading of shipments for multiple deliveries.”

Wallenborn’s dedicated GDP team were a strategic partner in this vital project:

  • providing vital operational and security intelligence
  • designing secure transportation routes
  • liaising with law enforcement agencies
  • contributing resources and expertise to enable a smooth rollout
  • supplying flexible capacity to distribute to 12 countries across Europe

www.wallenborn.com/healthcare


Continue reading